Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-21-037255

Director bought 909,000 shares at $11.00 ($9,999,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fairmount Funds Management LLC Director 2021-09-21 Purchase +909,000 $11.00 $9,999,000 938,233 I
Open-market purchases · 909,000 sh · avg $11.00 · $9,999,000
Loading xslF345X03/doc4.xml…